Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AstraZeneca’s Asthma Drug Receives Expanded Indication from FDA
AstraZeneca’s Asthma Drug Receives Expanded Indication from FDA
AstraZeneca’s Asthma Drug Receives Expanded Indication from FDA
Submitted by
admin
on February 1, 2017 - 9:33am
Source:
Xtalks
News Tags:
AstraZeneca
asthma
FDA
Symbicort
pediatrics
Headline:
AstraZeneca’s Asthma Drug Receives Expanded Indication from FDA
Do Not Allow Advertisers to Use My Personal information
